Step by Stepa HemeOncBuddy patient portal

Mercaptopurine (6-MP)

Illustration: Mercaptopurine (6-MP)

Say it: mer-kap-toh-PYOOR-een · Brand names: Purixan

Mercaptopurine is a chemotherapy pill that blocks leukemia cells from making the DNA they need to grow.

What it is

Mercaptopurine looks like one of the building blocks of DNA. Leukemia cells take it in and cannot make DNA the right way. The cells stop growing and die.

Often used for

How you get it

Mercaptopurine is a tablet or liquid you take at home, usually once a day, often for many months. Your team adjusts the dose based on your blood counts. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

At home

Questions to ask

Part of these treatment plans

Side effect guides

Sources

Quick answers

What is Mercaptopurine (6-MP)?
Mercaptopurine is a chemotherapy pill that blocks leukemia cells from making the DNA they need to grow. Brand names: Purixan.
What is Mercaptopurine (6-MP) used for?
acute lymphoblastic leukemia (ALL), as long-term maintenance treatment.
How is Mercaptopurine (6-MP) given?
Mercaptopurine is a tablet or liquid you take at home, usually once a day, often for many months. Your team adjusts the dose based on your blood counts. Your schedule may be different.
What are the common side effects of Mercaptopurine (6-MP)?
Low blood counts, which raise your risk of infection and bleeding. Nausea or vomiting. Poor appetite. Feeling tired. Mouth sores. Rash. Changes in liver blood tests.
When should I call my care team while taking Mercaptopurine (6-MP)?
A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher, or chills; Yellow skin or eyes, dark urine, or belly pain; Bleeding or bruising that will not stop, black or bloody stools, or blood in your urine; Vomiting so much you cannot keep the medicine or fluids down; Severe belly or back pain.
Which chemotherapy plans include Mercaptopurine (6-MP)?
C10403 (CALGB 10403), POMP.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.